Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
0.5390
-0.0322 (-5.64%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Biodesix Employees
Biodesix had 273 employees as of December 31, 2024. The number of employees increased by 56 or 25.81% compared to the previous year.
Employees
273
Change (1Y)
56
Growth (1Y)
25.81%
Revenue / Employee
$261,256
Profits / Employee
-$157,256
Market Cap
78.68M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 273 | 56 | 25.81% |
| Dec 31, 2023 | 217 | -28 | -11.43% |
| Dec 31, 2022 | 245 | 27 | 12.39% |
| Dec 31, 2021 | 218 | 18 | 9.00% |
| Dec 31, 2020 | 200 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BDSX News
- 5 days ago - Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types - GlobeNewsWire
- 7 weeks ago - Biodesix, Inc. (BDSX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results - GlobeNewsWire
- 2 months ago - Biodesix to Present at TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 2 months ago - Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 - GlobeNewsWire
- 3 months ago - Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited) - GlobeNewsWire
- 3 months ago - Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study - GlobeNewsWire
- 6 months ago - Biodesix, Inc. (BDSX) Q3 2024 Earnings Call Transcript - Seeking Alpha